According to PURE Bioscience latest financial reports the company has an operating margin of -1.93%, an increase of 6.28% to 2022. At the end of 2022 company had an operating margin of -1.82%.
Year | Operating Margin | Change |
---|---|---|
2023 | -1.93% | 6.28% |
2022 | -1.82% | 209.04% |
2021 | -0.59% | -101864.62% |
2020 | 0.00% | - |